Systems biology of immunity to MF59-adjuvanted versus nonadjuvanted trivalent seasonal influenza vaccines in early childhood
暂无分享,去创建一个
Helder I. Nakaya | Tao Dong | Mario Cortese | Bali Pulendran | Rino Rappuoli | Giuseppe Del Giudice | Daniel E. Zak | Alan Aderem | Vincenzo Cerundolo | Andrew J. Pollard | B. Pulendran | D. Zak | A. Aderem | R. Rappuoli | H. Nakaya | V. Cerundolo | A. Pollard | D. Kazmin | C. Siegrist | S. Bosinger | N. Patel | T. Dong | G. Del Giudice | Claire-Anne Siegrist | Steven E. Bosinger | E. Clutterbuck | Dmitri Kazmin | Lili Wang | Mario Cortese | Lili Wang | Nirav B. Patel | Dmitri A Kazmin | Elizabeth Clutterbuck
[1] Eva K. Lee,et al. Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans , 2009, Nature Immunology.
[2] Giuseppe Del Giudice,et al. The history of MF59® adjuvant: a phoenix that arose from the ashes , 2013, Expert review of vaccines.
[3] Jill P. Mesirov,et al. GSEA-P: a desktop application for Gene Set Enrichment Analysis , 2007, Bioinform..
[4] Sandra Romero-Steiner,et al. Molecular signatures of antibody responses derived from a systems biology study of five human vaccines , 2022 .
[5] F. Mosca,et al. Influenza A/H1N1 MF59-Adjuvanted Vaccine in Preterm and Term Children Aged 6 to 23 Months , 2011, Pediatrics.
[6] Patrick C. Wilson,et al. Rapid cloning of high-affinity human monoclonal antibodies against influenza virus , 2008, Nature.
[7] L. Brammer,et al. Influenza-Associated Pediatric Deaths in the United States, 2004–2012 , 2013, Pediatrics.
[8] V. Pascual,et al. Differences in antibody responses between trivalent inactivated influenza vaccine and live attenuated influenza vaccine correlate with the kinetics and magnitude of interferon signaling in children. , 2014, The Journal of infectious diseases.
[9] Mario Cortese,et al. Vaccine adjuvants alum and MF59 induce rapid recruitment of neutrophils and monocytes that participate in antigen transport to draining lymph nodes. , 2011, Vaccine.
[10] T. Vesikari,et al. MF59-adjuvanted influenza vaccine (FLUAD) in children: safety and immunogenicity following a second year seasonal vaccination. , 2009, Vaccine.
[11] Pablo Tamayo,et al. Gene signatures related to B‐cell proliferation predict influenza vaccine‐induced antibody response , 2014, European journal of immunology.
[12] Mark M. Davis,et al. Apoptosis and other immune biomarkers predict influenza vaccine responsiveness , 2014, Molecular Systems Biology.
[13] Audrey Kauffmann,et al. Bioinformatics Applications Note Arrayqualitymetrics—a Bioconductor Package for Quality Assessment of Microarray Data , 2022 .
[14] J. Yewdell,et al. MF59 Adjuvant Enhances Diversity and Affinity of Antibody-Mediated Immune Response to Pandemic Influenza Vaccines , 2011, Science Translational Medicine.
[15] B. Pulendran,et al. Distinct TLR adjuvants differentially stimulate systemic and local innate immune responses in nonhuman primates. , 2012, Blood.
[16] Volker Brauer,et al. Adjuvanted H5N1 vaccine induces early CD4+ T cell response that predicts long-term persistence of protective antibody levels , 2009, Proceedings of the National Academy of Sciences.
[17] Eva K. Lee,et al. Systems Biology of Seasonal Influenza Vaccination in Humans , 2011, Nature Immunology.
[18] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[19] M. Kolczak,et al. Effectiveness of the 2003–2004 Influenza Vaccine Among Children 6 Months to 8 Years of Age, With 1 vs 2 Doses , 2005, Pediatrics.
[20] Molly S Bray,et al. Integrative genomic analysis of the human immune response to influenza vaccination , 2013, eLife.
[21] T. Vesikari,et al. Oil-in-water emulsion adjuvant with influenza vaccine in young children. , 2011, The New England journal of medicine.
[22] R. Rappuoli,et al. Hemagglutination Inhibition Antibody Titers as a Correlate of Protection for Inactivated Influenza Vaccines in Children , 2011, The Pediatric infectious disease journal.
[23] A. Marchant,et al. Dissecting the Immune Response to MF59-adjuvanted and Nonadjuvanted Seasonal Influenza Vaccines in Children Less Than Three Years of Age , 2015, The Pediatric infectious disease journal.
[24] T. Jefferson,et al. Vaccines for preventing influenza in healthy children. , 2012, The Cochrane database of systematic reviews.